Could a breast cancer drug improve abortion care?
NCT ID NCT07767435
First seen Aug 17, 2026 · Last updated Aug 17, 2026
Summary
This study tests whether adding letrozole, a drug commonly used for breast cancer, to the standard medication misoprostol can improve the complete termination of second-trimester pregnancies (14-20 weeks). The trial will compare the combination against misoprostol alone in 80 women with a failed pregnancy. The main goal is to see if the combination leads to a higher rate of complete abortion, potentially making the process safer and more effective.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- letrozole combined with misoprostol
- What this could lead to
- If adding letrozole works, it could make second-trimester abortion procedures faster and more complete, reducing the need for additional surgical intervention.
- What could go wrong
- This is an early-phase trial with a small number of participants, so results may not be conclusive. Adding letrozole could also increase side effects without improving outcomes.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ABORTION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a common drug make abortion safer? new trial aims to find out
- New study seeks to uncover reasons behind late abortions
- Laughing gas eases abortion pain in new study
- Drug may ease emotional pain after pregnancy loss procedure
- Could a common allergy drug ease abortion pain?
- One pill to stop breast pain after pregnancy loss? new trial tests cabergoline